July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Retinal Vasculitis in HLA-B27 Associated Anterior Uveitis on Wide-Field Anigiography
Author Affiliations & Notes
  • Jie Gao
    opthalmology, Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, United States
  • Marina Peskina
    opthalmology, Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, United States
  • Marisa Walsh
    opthalmology, Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, United States
  • Peter Chang
    opthalmology, Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, United States
  • Stephen D Anesi
    opthalmology, Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, United States
  • Charles S Foster
    opthalmology, Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Jie Gao, None; Marina Peskina, None; Marisa Walsh, None; Peter Chang, None; Stephen Anesi, None; Charles S Foster, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4079. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jie Gao, Marina Peskina, Marisa Walsh, Peter Chang, Stephen D Anesi, Charles S Foster; Retinal Vasculitis in HLA-B27 Associated Anterior Uveitis on Wide-Field Anigiography. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4079.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : HLA-B27 associated uveitis is primarily thought to be an anterior segment uveitis. We performed a retrospective, observational study to review the incidence of retinal vasculitis on widefield fluorescein angiography (WF-FA) in our HLA-B27 anterior uveitis patient population at the Massachusetts Eye Research and Surgery Institute (MERSI).

Methods : Our database was searched for patients with the diagnosis of HLA-B27 associated uveitis. Inclusion criteria included a clinical diagnosis of unilateral anterior uveitis, HLA-B27 positive serology testing, and that the patient performed at least one WF-FA. Paitents with other identifiable causes of uveitis were excluded. 27 patients were found and their WF-FAs were examined to look for retinal vasculitis defined as: 1). Far-peripheral (FP) vasculitis involving vessels from the vortex veins out to the ora serrata. 2). Mid-peripheral (MP) vasculitis involving vessels beyond the main arcade vessels extending to the vortex veins. 3). Posterior-pole vasculitis (PP) involving any of the main arcade vessels.

Results : 7 of 27 patients (26%) show evidence of active retinal vasculitis on WF-FA. 1 of 7 patient (14%) had PP vasculitis occurring during an active anterior chamber (AC) flare-up. 2 of 7 patients (29%) had MP vasculitis despite no AC inflammation. 4 of 7 patients (57%) had FP vasculitis. Of the 4 patients with FP vasculitis, only 1 of them showing signs of active AC inflammation at time of examination, and this patient showed bilateral FF vasculitis despite the fellow eye showing no signs of AC inflammation. Another 1 of the 4 patients showed bilateral FP vasculitis despite both eyes showing no signs of AC inflammation.

9 total eyes showed retinal vasculitis. 3 of 9 eyes (33%) showed retinal vasculitis during episodes of active AC inflammation. 1 of the previous 3 eyes eventually had resolution of vasculitis with treatment. 6 of 9 eyes (67%) showed retinal vasculitis despite no active AC inflammation at time of clinical exam. 1 of the previous 6 showed resolution of vasculitis on treatment. Another 1 of the previous 6 developed vasculitis when treatment was temporarily stopped.

Conclusions : We concluded that retinal vasculitis is an under reported complication of HLA-B27 associated anterior uveitis. What is more striking is the fact that the majority of eyes that exhibited retinal vasculitis did not have active anterior chamber inflammation at the time of the exam.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×